Aperio Group LLC lifted its stake in Smith & Nephew plc (NYSE:SNN) by 2.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 387,796 shares of the medical equipment provider’s stock after acquiring an additional 8,503 shares during the quarter. Aperio Group LLC’s holdings in Smith & Nephew were worth $13,577,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently modified their holdings of SNN. Bessemer Group Inc. boosted its stake in shares of Smith & Nephew by 400.2% in the third quarter. Bessemer Group Inc. now owns 2,781 shares of the medical equipment provider’s stock worth $102,000 after buying an additional 2,225 shares during the last quarter. Steward Partners Investment Advisory LLC purchased a new stake in shares of Smith & Nephew in the fourth quarter worth about $126,000. Lbmc Investment Advisors LLC purchased a new stake in shares of Smith & Nephew in the third quarter worth about $206,000. First Allied Advisory Services Inc. purchased a new stake in shares of Smith & Nephew in the third quarter worth about $247,000. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Smith & Nephew by 0.9% in the second quarter. The Manufacturers Life Insurance Company now owns 7,437 shares of the medical equipment provider’s stock worth $260,000 after buying an additional 63 shares during the last quarter. Hedge funds and other institutional investors own 6.56% of the company’s stock.
A number of analysts have recently commented on the company. Zacks Investment Research upgraded Smith & Nephew from a “hold” rating to a “buy” rating and set a $43.00 target price on the stock in a research note on Wednesday, October 18th. Canaccord Genuity assumed coverage on Smith & Nephew in a research note on Wednesday, October 11th. They issued a “buy” rating and a $42.00 target price on the stock. Morgan Stanley downgraded Smith & Nephew from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 11th. Finally, JPMorgan Chase & Co. upgraded Smith & Nephew from a “neutral” rating to an “overweight” rating in a research note on Thursday, January 25th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $44.00.
TRADEMARK VIOLATION NOTICE: “Aperio Group LLC Buys 8,503 Shares of Smith & Nephew plc (SNN)” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.com-unik.info/2018/02/08/aperio-group-llc-buys-8503-shares-of-smith-nephew-plc-snn.html.
Smith & Nephew Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN).
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.